MUM1 and BCL6 but not HGAL are independent prognostic indicators of outcome in nodal diffuse large B-Cell lymphoma

被引：0
|
作者：
Wongchaowart, NT
Segota, E
Pohlman, B
Lossos, IS
Natkunam, Y
Levy, R
Jin, T
Hsi, ED
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Univ Miami, Miami, FL 33152 USA
[3] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
LABORATORY INVESTIGATION | 2006年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1167
引用
收藏
页码：252A / 252A
页数：1
相关论文
共 50 条
  • [31] PDL1 and MUM1 Expression Are Associated with Outcome in Primary Mediastinal Large B-cell Lymphoma
    Bledsoe, Jacob
    Redd, Robert
    Zukerberg, Lawrence
    Abramson, Jeremy
    Sohani, Aliyah R.
    MODERN PATHOLOGY, 2016, 29 : 336A - 337A
  • [32] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
    Kramer, MHH
    Hermans, J
    Wijburg, E
    Philippo, K
    Geelen, E
    van Krieken, JHJM
    de Jong, D
    Maartense, E
    Schuuring, E
    Kluin, PM
    BLOOD, 1998, 92 (09) : 3152 - 3162
  • [33] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
    Kurtz, David M.
    Scherer, Florian
    Newman, Aaron M.
    Craig, Alexander
    Jin, Michael
    Stehr, Henning
    Chabon, Jacob J.
    Esfahani, Mohammad
    Liu, Chih Long
    Zhou, Li
    Glover, Cynthia
    Visser, Brendan C.
    Poultsides, George
    Advani, Ranjana H.
    Maeda, Lauren S.
    Gupta, Neel K.
    Levy, Ronald
    Ohgami, Robert S.
    Davis, R. Eric
    Kunder, Christian A.
    Westin, Jason R.
    Diehn, Maximilian
    Alizadeh, Ash A.
    BLOOD, 2016, 128 (22)
  • [34] Concurrent rearrangement of BCL1 and BCL6 with a single immunoglobulin locus in a case of diffuse large B-cell lymphoma
    Ainle, F. Ni
    Hayden, P. J.
    Crosby, P.
    Murphy, K.
    McCarthy, D.
    Kelly, J.
    Neat, M. J.
    LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2655 - 2656
  • [35] Expression of MUM1/IRF4 correlates with prognosis in patients with diffuse large B-cell lymphoma
    Nagargoje, G
    Trzpuc, T
    Kampalath, B
    Abed, N
    Lorek, J
    Chang, C
    BLOOD, 2001, 98 (11) : 333A - 333A
  • [36] BCL2 and BCL6 atypical/unbalanced gene rearrangements in diffuse large B-cell lymphoma are indicators of an aggressive clinical course
    Tourneret, Alicia
    Alame, Melissa
    Rigau, Valerie
    Bauchet, Luc
    Fabbro, Michel
    De Oliveira, Laura
    Cacheux, Valere
    Costes, Valerie
    Lacheretz-Szablewski, Vanessa
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (10) : 650 - 656
  • [37] Prognostic Impact of D2-40 Expression and BCL6 Gene Rearrangement in Diffuse Large B-Cell Lymphoma
    Al-Sissi, A. A.
    Mourad, M. I.
    El-Sissy, N. A.
    Abd El-Aziz, S. M.
    Shalaby, A. A.
    JOURNAL OF PATHOLOGY, 2013, 231 : 21 - 21
  • [38] Incidence and prognostic significance of BCL2, BCL6 and C-MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer, MHH
    Hermans, J
    Philippo, K
    Geelen, E
    Wijburg, E
    vanKrieken, JHJM
    Schuuring, E
    Kluin, PM
    BLOOD, 1997, 90 (10) : 3916 - 3916
  • [39] Expression and Clinical Significance of Ki-67, CD10, BCL6, MUM1, c-MYC, and EBV in Diffuse Large B Cell Lymphoma Patients
    Sadeghipour, Alireza
    Taha, Seyed Reza
    Zadeh, Mahdieh Shariat
    Kosari, Farid
    Babaheidarian, Pegah
    Fattahi, Fahimeh
    Abdi, Navid
    Tajik, Fatemeh
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (07) : 309 - 321
  • [40] Outcome and prognostic factors in diffuse large B-cell lymphoma
    Mahajan, R.
    Yadav, B. S.
    Kumar, S.
    Gupta, A.
    Ghoshal, S.
    Sharma, S. C.
    Kumar, N.
    Kapoor, R.
    ANNALS OF ONCOLOGY, 2016, 27
12345